A Randomized, Double-Blind, Double-Dummy , Parallel Group, Multinational, Clinical Study to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Patients With Acute ST-Segment Elevation Myocardial Infarction Receiving Fibrinolytic Therapy

Sanofi48 个研究点分布在 48 个国家目标入组 20,506 人开始时间: 2002年10月最近更新: 2009年4月20日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方: Sanofi
入组人数: 20,506
试验地点: 48
主要终点: Composite of all-cause mortality and non-fatal myocardial re-infarction

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The primary objective of the study is to determine whether enoxaparin compared to unfractionated heparin will reduce the composite endpoint of all-cause mortality and non-fatal myocardial re-infarction within 30 days after randomization in patients with acute ST-segment elevation myocardial infarction who are eligible to receive fibrinolytic therapy

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Prevention
盲法: Double (Participant, Investigator)

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

未提供

排除标准

未提供

结局指标

主要结局

Composite of all-cause mortality and non-fatal myocardial re-infarction

次要结局

Composite of all-cause mortality, non-fatal myocardial re-infarction, and myocardial ischemia leading to urgent revascularization and non-fatal disabling stroke

研究者

发起方

Sanofi

申办方类型

Industry

研究点 (48)

Loading locations...

相似试验

已完成

4 期

Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)Acute Coronary Syndrome

NCT00077818Sanofi

终止

4 期

Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)Unstable Angina

NCT00518245Canadian Heart Research Centre11

撤回

2 期

A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)Small Cell Lung Cancer

NCT00916669Massachusetts General Hospital

已完成

1 期

Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®Enoxaparin

NCT04402762Indonesia University20

已完成

4 期

The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill PatientsCritical IllnessVenous Thrombosis

NCT00351663Shaare Zedek Medical Center39